Predict your next investment

Ergon Medical company logo
HEALTHCARE | Elective & Aesthetic Medicine
ergonmedical.co.za

See what CB Insights has to offer

About Ergon Medical

Ergon Medical specializes in the supply, distribution, and maintenance of cosmeceutical products and equipment to doctors and other qualified practitioners and therapists in the beauty industry. It is based in Johannesburg, South Africa.

Ergon Medical Headquarter Location

13 7th Avenue Edenvale

Johannesburg,

South Africa

Latest Ergon Medical News

Innovaderma PLC acquired Ergon Medical Limited for £1 million.

Dec 6, 2021

Link copied 05/02/2017 | 12:00am Innovaderma PLC (LSE:IDP) acquired Ergon Medical Limited for £1 million on May 2, 2017. The consideration will be satisfied by the issuance of ordinary shares at a discount of 25% to the average closing bid price three days prior to and three days post the announcement of the acquisition less the number of ordinary shares in the Innovaderma, which will be issued at the non-discounted average price to settle certain creditors totaling approximately £0.32 million. If, during any calendar year, Prolong returns a 20% EBIT of net sales then the sellers will be entitled to a £0.15 million bonus payment. Post-completion, Andy Zamar, founder of the London Psychiatry Centre and inventor of Prolong, will remain with the Group for the first 12 months, as a consultant of Innovaderma and will receive a consultancy fee of £4,166 per month. Claire Noyce of Hybridan LLP acted as sole broker while Shan Shan Willenbrock and David Roach of Cardew Group acted as PR advisor to Innovaderma.Innovaderma PLC (LSE:IDP) completed the acquisition of Ergon Medical Limited on May 2, 2017. As of May 8, 2017, as part of the consideration, 0.41 million ordinary shares were allotted as the initial consideration shares and 0.15 million ordinary shares were allotted as settlement for debts equating to £0.33 million. As of July 26, 2017, 0.05 million ordinary shares were allotted as the final consideration of shares. © S&P Capital IQ 2021 All news about INNOVADERMA PLC 11/22

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.